LAKE FOREST, Calif., Sept. 24, 2013 (GLOBE NEWSWIRE) -- Tenex Health today announced that Doug Kohrs, a current member of the Board of Directors, will assume the role of Executive Chairman effective immediately. Board Member Tommy Thompson, former governor of Wisconsin and former Secretary of the United States Department of Health and Human Services said of Kohrs' appointment, "The company has successfully proven the clinical and commercial strength of the TX System. As we focus on broader market expansion, Doug's extensive experience as a medical device CEO will provide significant benefit to customers, employees, and shareholders."
Mr. Kohrs brings significant operating experience to his new role as Executive Chairman at Tenex Health. He has over 30 years experience in the medical device industry and has spent 15 of those years as a chief executive of public and private companies. Doug has formerly served as CEO of Tornier, CEO of American Medical Systems, and was a founding member of Spine-Tech. Over his successful career in medical devices he has also served on the Board of Directors of fifteen different medical device companies.
Doug Kohrs commented, "I am excited to serve in this role and help the company fully optimize the commercial and clinical opportunities that reside within this ground-breaking technology. I look forward to a bright future for Tenex Health."
Current Board Chairman Ivan Mijatovic will remain on the Board of Directors. In addition, Ivan will assume the role of Chief Financial Officer on an interim basis and will oversee the search for a permanent CFO.
About Tenex Health, Inc.
Tenex Health, Inc. (www.tenexhealth.com) (www.tenexhealthpatient.com) develops and markets innovative therapies for the treatment of tendon pain due to trauma or repetitive motion injuries. The minimally invasive technique utilizes the company's proprietary TX MicroTip™ handpiece to cut and debride diseased tissue in an outpatient setting in under 20 minutes, using only a local anesthetic. Since the surrounding healthy tendon tissue is not disturbed, patients enjoy less discomfort and faster recovery times versus traditional open surgical procedures.
CONTACT: Tenex Health, Inc. MaryAnn Tingley Vice-President of Marketing 949-454-7500 x 245